Advanced Research in Clinical Pharmacology and Epidemiology
A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Epidemiology & Public Health".
Deadline for manuscript submissions: 31 December 2025 | Viewed by 68
Special Issue Editor
Special Issue Information
Dear Colleagues,
Clinical pharmacology and epidemiology are two interrelated disciplines that play a pivotal role in understanding drug effects, optimizing therapeutic strategies, and assessing population health outcomes. Over the years, advancements in pharmacokinetics, pharmacodynamics, and pharmacogenomics have transformed drug development and personalized medicine.
The focus is on translating preclinical research to clinical application by integrating clinical pharmacology with epidemiological methodologies to enhance therapeutic outcomes and drive evidence-based medicine. The scope includes novel experimental approaches, real-world data analyses, and computational models that bridge the gap between bench science and clinical application.
This Special Issue will showcase emerging trends such as, translational drug and formulation development process, preclinical and clinical evidences on pharmacology, drug safety, pharmacoepidemiology, pharmacogenomics, precision medicine, clinical relevance of emerging nanoplatforms and biomarkers, AI and machine learning-based drug development processes.
We invite submissions of original research, comprehensive review, and cutting-edge methodologies. Areas of interest include preclinical research on drug and formulation development, drug delivery, pharmacokinetic and pharmacodynamic modeling, comparative effectiveness and safety studies, population based drug assessment and utilization studies, reviews correlating drug development process and preclinical/clinical pharmacology, epidemiology-based pharmacological assessment, new studies report pharmacovigilance, and application of AI based applications and methodologies in pharmacology research.
Dr. Dnyandev Gadhave
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- clinical pharmacology
- epidemiology
- pharmacokinetics
- pharmacodynamics
- drug delivery
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
